143 related articles for article (PubMed ID: 9683763)
1. Effective TAE therapy using Lipiodol with epirubicin for liver metastases of nonfunctioning islet cell carcinoma of the pancreas.
Naka T; Ashida K; Takahashi S; Kaneko T; Mizusawa K; Kaibara N
J Hepatobiliary Pancreat Surg; 1998; 5(1):108-12. PubMed ID: 9683763
[TBL] [Abstract][Full Text] [Related]
2. [Malignant islet cell tumor of the pancreas with multiple liver metastases effectively treated by transcatheter arterial embolization with degradable starch microspheres--a case report].
Takahashi H; Tono T; Matsushita M; Yasue A; Okada K; Hata T; Kano T; Iwazawa T; Matsui S; Nakano Y; Yano H; Kinuta M; Okamura J; Monden T
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1936-9. PubMed ID: 11086449
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of malignant pancreatic islet cell tumors].
Egorov AV; Kuzin NM; Kondrashin SA; Lotov AN; Kazantseva IA; Kuznetsov NS; Gurevich LE; Lakreeva MG
Khirurgiia (Mosk); 2000; (5):13-7. PubMed ID: 10842959
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
6. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
7. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.
House MG; Cameron JL; Lillemoe KD; Schulick RD; Choti MA; Hansel DE; Hruban RH; Maitra A; Yeo CJ
J Gastrointest Surg; 2006 Jan; 10(1):138-45. PubMed ID: 16368504
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.
Dominguez S; Denys A; Madeira I; Hammel P; Vilgrain V; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):151-7. PubMed ID: 10741928
[TBL] [Abstract][Full Text] [Related]
10. [Management of nonfunctioning islet cell tumors of the pancreas].
Liang H; Wang XN; Wang BG; Pan Y; Ding XW; Hao XS
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):457-60. PubMed ID: 17974283
[TBL] [Abstract][Full Text] [Related]
11. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
Kim YH; Ajani JA; Carrasco CH; Dumas P; Richli W; Lawrence D; Chuang V; Wallace S
Cancer Invest; 1999; 17(7):474-8. PubMed ID: 10518191
[TBL] [Abstract][Full Text] [Related]
12. [A case of gastric cancer with multiple liver metastasis treated with transarterial and transportal chemoembolization of tegafur/lipiodol and epirubicin].
Uchino R; Yamaguchi T; Obayashi H; Yasugawa T; Sakaguchi H
Gan To Kagaku Ryoho; 1992 Jan; 19(1):119-21. PubMed ID: 1309630
[TBL] [Abstract][Full Text] [Related]
13. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
14. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
[TBL] [Abstract][Full Text] [Related]
15. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
[TBL] [Abstract][Full Text] [Related]
16. Nonfunctioning islet cell carcinoma of the pancreas.
Neeleman S; Demeure MJ
Curr Treat Options Oncol; 2002 Aug; 3(4):355-60. PubMed ID: 12074772
[TBL] [Abstract][Full Text] [Related]
17. [Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol].
Inoue Y; Nakamura H; Yano M; Akashi H; Mizumoto S; Yamasaki K
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1665-7. PubMed ID: 8060143
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
19. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
[TBL] [Abstract][Full Text] [Related]
20. Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
Hung JS; Chang MC; Lee PH; Tien YW
World J Surg; 2007 Dec; 31(12):2392-7. PubMed ID: 17960455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
